Cargando…
CD80 expression is upregulated by TP53 activation in human cancer epithelial cells
CD80 is recognized as one of the most potent costimulatory molecules by which immune cells limit cancer progression; however, the current understanding of the regulation of its expression on human tumor cells is limited. The TP53 tumor suppressor plays a critical role in cancer and its significant r...
Autores principales: | Scarpa, Melania, Marchiori, Chiara, Scarpa, Marco, Castagliuolo, Ignazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023236/ https://www.ncbi.nlm.nih.gov/pubmed/33868791 http://dx.doi.org/10.1080/2162402X.2021.1907912 |
Ejemplares similares
-
CD80 expression promotes immune surveillance in Barrett’s metaplasia
por: Scarpa, Melania, et al.
Publicado: (2019) -
CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis
por: Scarpa, Marco, et al.
Publicado: (2016) -
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells
por: Marchiori, Chiara, et al.
Publicado: (2019) -
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis
por: Scarpa, Marco, et al.
Publicado: (2015) -
Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
por: Kotsafti, Andromachi, et al.
Publicado: (2020)